No anaphylaxis has been reported due to Synagis . As with other immunoglobulin preparations, RespiGam may interfere with immune responses to live virus vaccines, such as measles, mumps, and rubella. If such a vaccine is given during or within 10 months of RespiGam infusions, re-immunization is recommended. Synagis has no effect on immune responses to live virus vaccines. Two medications are available to high risk infants for the prevention of serious RSV infection.
Respiratory infections caused by viruses are common during the winter months.
RSV infections can cause upper respiratory infections, like a cold, or it can cause more serious lower respiratory infections, such as pneumonia. RSV infections are particularly severe in infants and young children with lung problems. By age 5 all children will have been infected with the virus at least once. One medication called RespiGam is similar to standard immune globulins which are commonly used to help patients fight infections. The only difference is that this immune globulin contains high levels of RSV antibodies to help fight RSV infection.